Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Nearly 75% of Americans are classified as overweight or obese. Addressing our nation's health crisis requires much more than ...

Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy ...

Weight-loss medications surged in popularity this year. A survey from Kaiser Family Foundation found one in eight adults have taken drugs like Ozempic, Wegovy and Mounjaro. Demand for the drugs has ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...